Helyx Industries S.p.A. is an Italian healthcare biotechnology company specializing in genetics-driven medical solutions. The company focuses on developing innovative diagnostic and theranostic platforms designed to improve disease detection, patient monitoring, and personalized treatment pathways. Its technologies aim to deliver advanced molecular diagnostics that can be deployed close to patients, supporting more efficient and accessible healthcare workflows. Helyx Industries S.p.A. operates within the broader pharmaceuticals and biotechnology sector, targeting clinical laboratories, healthcare providers, and research institutions that require high-precision genetic and molecular testing tools. The company emphasizes proprietary and patented technologies, with a vertically integrated model that supports in-house development and commercialization of its diagnostic systems. Through its focus on transformative diagnostic products, Helyx Industries S.p.A. contributes to the evolving field of precision medicine and modern healthcare diagnostics.
Markedsdata leveret af TwelveData og Morningstar